Impact of immune checkpoint inhibitors on subsequent chemotherapy

被引:0
|
作者
Watanabe, H. [1 ]
Kubo, T. [2 ]
Kudo, K. [3 ]
Minami, D. [4 ]
Murakami, T. [5 ]
Ochi, N. [6 ]
Ninomiya, T. [1 ]
Harada, D. [7 ]
Yasugi, M. [8 ]
Takeda, H. [9 ]
Ichihara, E. [1 ]
Ohashi, K. [1 ]
Hotta, K. [10 ]
Tabata, M. [2 ]
Maeda, Y. [11 ]
Kiura, K. [1 ]
机构
[1] Okayama Univ Hosp, Allergy & Resp Med, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Clin Oncol, Okayama, Japan
[3] Iwakuni Med Ctr, Resp Med, Iwakuni, Japan
[4] Okayama Med Ctr, Resp Med, Okayama, Japan
[5] Japanese Red Cross Soc Himeji Hosp, Resp Med, Himeji, Hyogo, Japan
[6] Kawasaki Med Sch, Gen Internal Med 4, Okayama, Japan
[7] Shikoku Canc Ctr, Resp Med, Matsuyama, Ehime, Japan
[8] Chugoku Cent Hosp, Resp Med, Fukuyama, Hiroshima, Japan
[9] Tsuyama Chuo Hosp, Resp Med, Tsuyama, Japan
[10] Okayama Univ Hosp, Innovat Clin Med, Okayama, Japan
[11] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Hematol & Oncol, Okayama, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
439P
引用
收藏
页码:134 / 134
页数:1
相关论文
共 50 条
  • [1] Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
    Galluzzi, Lorenzo
    Humeau, Juliette
    Buque, Aitziber
    Zitvogel, Laurence
    Kroemer, Guido
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (12) : 725 - 741
  • [2] Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
    Lorenzo Galluzzi
    Juliette Humeau
    Aitziber Buqué
    Laurence Zitvogel
    Guido Kroemer
    Nature Reviews Clinical Oncology, 2020, 17 : 725 - 741
  • [3] Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
    Liu, Wei
    Zhang, Lei
    Xiu, Zhiming
    Guo, Jian
    Wang, Liye
    Zhou, Yue
    Jiao, Yang
    Sun, Meiyan
    Cai, Jianhui
    ONCOTARGETS AND THERAPY, 2020, 13 : 7229 - 7241
  • [4] The impact of immune checkpoint inhibitors on actinic keratosis
    Cox, Charlotte
    Brown, Susan
    Ladwa, Rahul
    Khosrotehrani, Kiarash
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 92 - 92
  • [5] Impact of prior immune checkpoint inhibitors on haematological toxicity in phase I patients receiving chemotherapy
    Garces, A. H. Ingles
    Ang, J. E.
    Ameratunga, M.
    Chenard-Poirier, M.
    Dolling, D.
    Sundar, R.
    Kaye, S.
    de Bono, J.
    Banerji, U.
    Lopez, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Do immune checkpoint inhibitors increase sensitivity to salvage chemotherapy?
    Saleh, Khalil
    Khalifeh-Saleh, Nadine
    Kourie, Hampig Raphael
    Nasr, Fadi
    Chahine, Georges
    IMMUNOTHERAPY, 2018, 10 (03) : 163 - 165
  • [7] Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors
    Sasatani, Yuika
    Ojima, Eiji
    Satoh, Hiroaki
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (02) : 523 - 525
  • [8] Bloody pericardial effusion during chemotherapy with immune checkpoint inhibitors
    Yuika Sasatani
    Eiji Ojima
    Hiroaki Satoh
    Cancer Immunology, Immunotherapy, 2023, 72 : 523 - 525
  • [9] Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
    Park, Benjamin C.
    Lee, Aaron X. T.
    Ye, Fei
    Turker, Isik
    Johnson, Douglas B.
    BMC CANCER, 2022, 22 (01)
  • [10] Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
    Hou, Chuandong
    Wang, Zining
    Lu, Xuechun
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (01): : 24 - 30